218 related articles for article (PubMed ID: 24823997)
1. [Perioperative management of anticoagulation].
Eisele R; Melzer N; Bramlage P
Chirurg; 2014 Jun; 85(6):513-9. PubMed ID: 24823997
[TBL] [Abstract][Full Text] [Related]
2. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
Klamroth R; Gottstein S; Essers E; Landgraf H
Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH
J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R
Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666
[TBL] [Abstract][Full Text] [Related]
5. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
6. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
8. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.
Douketis JD
Thromb Res; 2002 Oct; 108(1):3-13. PubMed ID: 12586125
[TBL] [Abstract][Full Text] [Related]
9. Mechanical heart valve recipients: anticoagulation in patients with genetic variations of phenprocoumon metabolism.
Brehm K; Schack J; Heilmann C; Blanke P; Geissler HJ; Beyersdorf F
Eur J Cardiothorac Surg; 2013 Aug; 44(2):309-14; discussion 314-5. PubMed ID: 23423913
[TBL] [Abstract][Full Text] [Related]
10. Perioperative Management of Anticoagulants.
Irizarry-Alvarado JM; Seim LA
Curr Clin Pharmacol; 2017; 12(3):145-151. PubMed ID: 28828987
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural bridging anticoagulation: current perspectives.
Palaniswamy C; Selvaraj DR
Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
[TBL] [Abstract][Full Text] [Related]
12. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
13. Update on perioperative bridging in patients on chronic oral anticoagulation.
Faltas B; Kouides PA
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1533-9. PubMed ID: 19954315
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
15. [Perioperative management of platelet function and anticoagulation in geriatric patients].
Lenzen-Großimlinghaus R
Chirurg; 2022 Mar; 93(3):266-273. PubMed ID: 34665284
[TBL] [Abstract][Full Text] [Related]
16. [Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
MMW Fortschr Med; 2005 Jun; 147(22):51. PubMed ID: 15977637
[No Abstract] [Full Text] [Related]
17. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
Beinema M; Brouwers JR; Schalekamp T; Wilffert B
Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
[TBL] [Abstract][Full Text] [Related]
18. [Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?].
Buerke M; Hoffmeister HM
Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):105-110. PubMed ID: 28074293
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients-a retrospective study of emergency department consultations.
Müller M; Schlittler F; Schaller B; Nagler M; Exadaktylos AK; Sauter TC
Clin Oral Investig; 2019 May; 23(5):2273-2278. PubMed ID: 30291493
[TBL] [Abstract][Full Text] [Related]
20. Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach.
Douketis JD
Hosp Pract (1995); 2011 Oct; 39(4):41-54. PubMed ID: 22056822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
